Anton Sam M, Gayed Andrew, Chadwick Jeffrey W, Addamo Paul, Holland Julian N, Wong Mark E, Benavidez Rosa, Melville James C
Resident, Department of Oral and Maxillofacial Surgery, UTHealth School of Dentistry, Houston, TX.
Resident, Department of Oral and Maxillofacial Surgery, UTHealth School of Dentistry, Houston, TX.
J Oral Maxillofac Surg. 2025 Aug;83(8):1024-1031. doi: 10.1016/j.joms.2025.05.002. Epub 2025 May 13.
Tissue engineering (TE) offers a potential alternative to fibula-free flap (FFF) reconstruction and may reduce surgical complexity, hospital stay, and health care costs.
The purpose of this study is to estimate and compare the cost-effectiveness of immediate TE and FFF reconstruction.
STUDY DESIGN, SETTING, SAMPLE: This study was designed as a retrospective cohort conducted at the University of Texas Health Science Center at Houston from November 2015 to March 2024. Exclusion criteria included subjects with malignant pathologies, those treated with only a fasciocutaneous graft, cases of osteoradionecrosis, and those with incomplete records.
The primary predictor variable was the type of reconstruction method, either TE bone grafts or FFF reconstruction.
The main outcome variable was cost-effectiveness which was defined as cost per successful reconstruction. Successful reconstruction was defined as complete union more than 1 year postoperatively without the need for revision surgery and the absence of postoperative complications requiring take-back surgery.
Covariates include age, sex, defect size, and American Society of Anesthesiologists classification.
R statistical software was used for data analysis. Statistical significance was defined as P < .05.
The sample was composed of 31 subjects with a mean age of 44.97 ± 18.46 years for TE and 41.93 ± 18.23 years for FFF (P = .7). There were 18 (58%) and 13 (42%) subjects in TE and FFF, respectively. The proportion of successful reconstructions was 95% (n = 18) for TE and 77% (n = 13) for FFF (P = .6). The mean total hospital charges for TE were $247,172 ± $54,080 (P < .001) and $423,008 ± $59,571.75 (P < .001) for FFF. The cost per successful reconstruction was $261,711.64 for TE and $549,910.40 for FFF.
TE may be a more cost-effective alternative to FFF, providing comparable reconstructive success with reduced cost, surgical time, and hospital resource utilization.
组织工程(TE)为游离腓骨瓣(FFF)重建提供了一种潜在的替代方案,可能会降低手术复杂性、缩短住院时间并降低医疗成本。
本研究的目的是评估和比较即刻TE和FFF重建的成本效益。
研究设计、设置、样本:本研究设计为一项回顾性队列研究,于2015年11月至2024年3月在休斯顿德克萨斯大学健康科学中心进行。排除标准包括患有恶性疾病的受试者、仅接受筋膜皮瓣移植治疗的受试者、放射性骨坏死病例以及记录不完整的受试者。
主要预测变量是重建方法的类型,即TE骨移植或FFF重建。
主要结局变量是成本效益,定义为每次成功重建的成本。成功重建定义为术后1年以上完全愈合,无需翻修手术,且无需要回手术室手术的术后并发症。
协变量包括年龄、性别、缺损大小和美国麻醉医师协会分级。
使用R统计软件进行数据分析。统计学显著性定义为P < .05。
样本包括31名受试者,TE组的平均年龄为44.97±18.46岁,FFF组为41.93±18.23岁(P = .7)。TE组有18名(58%)受试者,FFF组有13名(42%)受试者。TE组的成功重建比例为95%(n = 18),FFF组为77%(n = 13)(P = .6)。TE组的平均总住院费用为247,172±54,080美元(P < .001),FFF组为423,008±59,571.75美元(P < .001)。每次成功重建的成本,TE组为261,711.64美元,FFF组为549,910.40美元。
TE可能是比FFF更具成本效益的替代方案,在重建成功率相当的情况下,可降低成本、缩短手术时间并减少医院资源利用。